Literature DB >> 19365812

Stem cell research in Asia: a critical view.

Douglas Sipp1.   

Abstract

Stem cell research stands as a high-priority field in many countries across the Asia-Pacific region, and the past decade has seen remarkable investment into facilities and programs intended to increase competitiveness in the drive to find clinical applications. In the years roughly framed by Korean cloner Woo-Suk Hwang's meteoric ascent and fall, speculation was rampant that Asia was poised to overtake the West in this field of science. But that potential remains unfulfilled. In this article, I will look at some of the deficits in infrastructure and governance that underlie the East-West stem cell gap, and suggest a number of measures that might be taken to remedy them. (c) 2009 Wiley-Liss, Inc.

Mesh:

Year:  2009        PMID: 19365812     DOI: 10.1002/jcb.22160

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  3 in total

1.  Chinese newspaper coverage of (unproven) stem cell therapies and their providers.

Authors:  Ubaka Ogbogu; Li Du; Christen Rachul; Lisa Bélanger; Timothy Caulfield
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

Review 2.  The unregulated commercialization of stem cell treatments: a global perspective.

Authors:  Douglas Sipp
Journal:  Front Med       Date:  2011-10-01       Impact factor: 4.592

3.  Sino-Canadian collaborations in stem cell research: a scientometric analysis.

Authors:  Sarah E Ali-Khan; Monali Ray; Dominique S McMahon; Halla Thorsteinsdóttir
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.